Moderna said its mRNA-1273 coronavirus vaccine has been sent to the National Institute of Allergy and Infectious Diseases for a planned phase-one study.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,